West Pharmaceutical Services, Inc.
WST Healthcare Medical Instruments & Supplies
West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow WST
West Pharmaceutical Services, Inc. (WST) Book value per share
West Pharmaceutical Services, Inc.'s book value per share at the end of fiscal 2025 was 43.9×, up 19.6% from 36.7× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 42.2×. Over the past ten years it has ranged from 14.2× (fiscal 2015) to 43.9× (fiscal 2025) — the current reading is the highest in ten years. West Pharmaceutical Services, Inc. ranks 9th of 55 Medical Instruments & Supplies companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 43.9× | 19.55% |
| FY2024 | 36.7× | (5.24%) |
| FY2023 | 38.8× | 7.45% |
| FY2022 | 36.1× | 14.97% |
| FY2021 | 31.4× | 25.09% |
| FY2020 | 25.1× | 18.04% |
| FY2019 | 21.3× | 12.52% |
| FY2018 | 18.9× | 9.09% |
| FY2017 | 17.3× | 13.60% |
| FY2016 | 15.2× | 7.21% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 42.2× | 1.69% |
| Mar 2026 | 41.5× | (5.45%) |
| Dec 2025 | 43.9× | 3.94% |
| Sep 2025 | 42.3× | 4.18% |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BDX Becton, Dickinson and Company compare | 88.9× |
| RMD ResMed Inc. compare | 45.3× |
| ALC Alcon compare | 44.4× |
| COO The Cooper Companies, Inc. compare | 43.2× |
| WST West Pharmaceutical Services, Inc. | 42.2× |
| RGEN Repligen Corporation compare | 37.4× |
| SOLV Solventum Corporation compare | 27.8× |
| MDLN Medline Inc. compare | 22.3× |
| BAX Baxter International Inc. compare | 12.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on WST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement